BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20211224)

  • 1. Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach.
    Elston MS; Clifton-Bligh RJ
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):48-54. PubMed ID: 20211224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
    Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
    Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach.
    Wierinckx A; Raverot G; Nazaret N; Jouanneau E; Auger C; Lachuer J; Trouillas J
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):30-9. PubMed ID: 20211685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
    Takahashi-Yanaga F; Kahn M
    Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt connection to tumorigenesis.
    Behrens J; Lustig B
    Int J Dev Biol; 2004; 48(5-6):477-87. PubMed ID: 15349822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt signaling pathway has tumor suppressor properties in retinoblastoma.
    Tell S; Yi H; Jockovich ME; Murray TG; Hackam AS
    Biochem Biophys Res Commun; 2006 Oct; 349(1):261-9. PubMed ID: 16930536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
    Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
    Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of Wnt pathway components in human salivary gland tumors.
    Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
    Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
    Han JI; Kim DY; Na KJ
    Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
    Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
    Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
    Wilusz M; Majka M
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
    Boerboom D; White LD; Dalle S; Courty J; Richards JS
    Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
    Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
    Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.